These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. DC-based cancer vaccines. Gilboa E J Clin Invest; 2007 May; 117(5):1195-203. PubMed ID: 17476349 [TBL] [Abstract][Full Text] [Related]
9. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Tacken PJ; de Vries IJ; Torensma R; Figdor CG Nat Rev Immunol; 2007 Oct; 7(10):790-802. PubMed ID: 17853902 [TBL] [Abstract][Full Text] [Related]
10. Dendritic cell vaccines in melanoma: from promise to proof? Lesterhuis WJ; Aarntzen EH; De Vries IJ; Schuurhuis DH; Figdor CG; Adema GJ; Punt CJ Crit Rev Oncol Hematol; 2008 May; 66(2):118-34. PubMed ID: 18262431 [TBL] [Abstract][Full Text] [Related]
11. On the road to a tumor cell vaccine: 20 years of cellular immunotherapy. Yannelli JR; Wroblewski JM Vaccine; 2004 Nov; 23(1):97-113. PubMed ID: 15519713 [TBL] [Abstract][Full Text] [Related]
12. HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. Santin AD; Bellone S; Palmieri M; Ravaggi A; Romani C; Tassi R; Roman JJ; Burnett A; Pecorelli S; Cannon MJ Gynecol Oncol; 2006 Mar; 100(3):469-78. PubMed ID: 16249018 [TBL] [Abstract][Full Text] [Related]
13. Dendritic cells and tumor immunity. Gunzer M; Jänich S; Varga G; Grabbe S Semin Immunol; 2001 Oct; 13(5):291-302. PubMed ID: 11502164 [TBL] [Abstract][Full Text] [Related]
14. Dendritic cell-based immunotherapy. Osada T; Clay TM; Woo CY; Morse MA; Lyerly HK Int Rev Immunol; 2006; 25(5-6):377-413. PubMed ID: 17169781 [TBL] [Abstract][Full Text] [Related]
15. Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination. Liu G; Black KL; Yu JS Expert Rev Vaccines; 2006 Apr; 5(2):233-47. PubMed ID: 16608423 [TBL] [Abstract][Full Text] [Related]
16. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
17. Optimizing dendritic cell-based immunotherapy for cancer. Zhong H; Shurin MR; Han B Expert Rev Vaccines; 2007 Jun; 6(3):333-45. PubMed ID: 17542749 [TBL] [Abstract][Full Text] [Related]
18. Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma. Sun K; Wang L; Zhang Y Cell Mol Immunol; 2006 Jun; 3(3):197-203. PubMed ID: 16893500 [TBL] [Abstract][Full Text] [Related]
19. Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts. Li L; Giannopoulos K; Reinhardt P; Tabarkiewicz J; Schmitt A; Greiner J; Rolinski J; Hus I; Dmoszynska A; Wiesneth M; Schmitt M Int J Oncol; 2006 Apr; 28(4):855-61. PubMed ID: 16525634 [TBL] [Abstract][Full Text] [Related]